Opinion of the High Council for Public Health regarding the mandatory minimum information requirements for advertising the Priorix® measles-rubella-mumps vaccine.

Author(s): Haut Conseil de la Santé Publique

Publishing year: 2011

Pages: 133

Weekly Epidemiological Bulletin, 2011, n° 10-11, p. 133

In relation to

Our latest news

news

Seniors, pregnant women, and nursing home staff: What is the status of their...

news

Winter Illnesses: A Dynamic and Accessible Way to Track the Spread of...

news

SIBCA 2026: The UrBaCS network presents its solutions for cities and...